Jonathan Dreyfuss, PhD

Joslin Diabetes Research Center
Boston, Massachusetts, United States

Disclosure information not submitted.

Presentation(s):

• SAT-087 - A Case Series on the Compassionate Use of Ersodetug, an Insulin Receptor Modulating Antibody, in Patients with Refractory Hypoglycemia Due to Malignant Insulin-Secreting Tumors

  Saturday, June 13, 2026
  9:30 AM - 4:30 PM CT